Dual antiplatelet therapy
Showing 1 - 25 of >10,000
Intracranial Aneurysm, Stent Complication Trial (Ticagrelor monotherapy, Dual Antiplatelet Therapy)
Not yet recruiting
- Intracranial Aneurysm
- Stent Complication
- Ticagrelor monotherapy
- Dual Antiplatelet Therapy
- (no location specified)
Aug 23, 2023
Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy Trial in Beijing (De-escalated Dual
Recruiting
- Coronary Artery Disease
- +6 more
- De-escalated Dual Antiplatelet Therapy
- Dual Antiplatelet Therapy
-
Beijing, ChinaFuwai Hospital
Dec 13, 2022
Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)
Not yet recruiting
- Elevated Lipoprotein(a) Level
- +3 more
- 24 Months DAPT
- 12 Months DAPT
-
Beijing, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Chi
Aug 26, 2023
Coronary Artery Disease Trial (Angiolite: Sirolimus-eluting stent, Xience: Sirolimus-eluting stent, 1-month DAPT)
Not yet recruiting
- Coronary Artery Disease
- Angiolite: Sirolimus-eluting stent
- +3 more
- (no location specified)
Jul 11, 2023
Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Coronary Artery Disease Trial in Bern (Algorithm-guided
Not yet recruiting
- Percutaneous Coronary Intervention
- +2 more
- Algorithm-guided DAPT duration
- Standard-of-care DAPT duration
-
Bern, SwitzerlandBern University Hospital
Feb 16, 2023
Acute Coronary Syndrome Trial in São Paulo (Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid
Recruiting
- Acute Coronary Syndrome
- Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
- Monotherapy: Ticagrelor alone OR Prasugrel alone
-
São Paulo, BrazilHospital Israelita Albert Einstein
Mar 2, 2023
Acute Coronary Syndrome Trial in Kyoto (No aspirin, 1-month DAPT)
Recruiting
- Acute Coronary Syndrome
- No aspirin
- 1-month DAPT
-
Kyoto, JapanKyoto University Graduate School of Medicine
Nov 16, 2022
Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual
Recruiting
- Atrial Fibrillation
- short postimplantation dual antiplatelet therapy
- +3 more
-
Warsaw, Mazowieckie, PolandNational Institute of Cardiology
Dec 14, 2022
Acute Coronary Syndrome, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)
Recruiting
- Acute Coronary Syndrome
- +2 more
- Genoss DES™ stent
-
Wonju, Gangwon State, Korea, Republic ofWonju Severance Christian Hospital
Oct 4, 2023
Coronary Artery Disease, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)
Recruiting
- Coronary Artery Disease
- +2 more
- Genoss DES™ stent
-
Wŏnju, Gangwon State, Korea, Republic ofWonju Severance Christian Hospital
Oct 4, 2023
Coronary Artery Disease Trial in Amsterdam
Not yet recruiting
- Coronary Artery Disease
-
Amsterdam, Noord-Holland, Netherlands
- +1 more
Sep 26, 2022
Ischemic Heart Disease Trial in Seoul (Clopidogrel monotherapy, Aspirin monotherapy, zotarolimus-eluting stent (Resolute Onyx
Recruiting
- Ischemic Heart Disease
- Clopidogrel monotherapy
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Oct 13, 2022
Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin Trial in Shinjuku (Aspirin group, Non-antithrombotic
Recruiting
- Aortic Stenosis
- +4 more
- Aspirin group
- Non-antithrombotic group
-
Shinjuku, Tokyo, JapanKeio University Hospital
Aug 17, 2023
Tracheotomy With and Without Dual Antiplatelet Therapy
Recruiting
- Tracheostomy Hemorrhage
- Tracheotomy
-
Nidda, GermanyNeurologische Klinik Bad Salzhausen
Oct 29, 2022
Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual
Recruiting
- Atrial Fibrillation
- short postimplantation dual antiplatelet therapy
- +3 more
-
Warsaw, Mazowieckie, PolandNational Institute of Cardiology
Jun 30, 2022
Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease Trial in Messina, Rivoli (P2Y12 inhibitor
Not yet recruiting
- Dual Antiplatelet Therapy
- +2 more
- P2Y12 inhibitor de-escalation
-
Messina, Italy
- +1 more
Jun 12, 2023
Bleeding and Ischemic Risk
Completed
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Percutaneous coronary intervention
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Oct 13, 2023
Coronary Artery Disease Trial in Kyoto (1-month DAPT, 12-month DAPT)
Active, not recruiting
- Coronary Artery Disease
- 1-month DAPT
- 12-month DAPT
-
Kyoto, JapanDivision of Cardiology, Kyoto University Hospital
Jan 10, 2022
Aneurysm Cerebral (Unruptured) Trial in New York (Endovascular Neurosurgery)
Recruiting
- Aneurysm Cerebral (Unruptured)
- Endovascular Neurosurgery
-
New York, New YorkMontefiore Medical Center Department of Neurosurgery
Dec 13, 2021
Percutaneous Intervention Trial in Shatin (Orsiro Mission, Resolute Onyx)
Recruiting
- Percutaneous Intervention
- Orsiro Mission
- Resolute Onyx
-
Shatin, Hong KongThe Chinese University of Hong Kong
Sep 19, 2022
Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul
Completed
- Coronary Artery Disease
- +2 more
-
Seoul, Korea, Republic ofYoung-Hyo Lim
Feb 24, 2023
Coronary Artery Disease Trial in Rome (Ticagrelor, acetylsalicylic acid)
Recruiting
- Coronary Artery Disease
- Ticagrelor
- acetylsalicylic acid
-
Rome, ItalyUniversità Campus Bio-Medico di Roma
Jul 19, 2022
Ticagrelor Versus Clopidogrel for CMD in AMI: A Retrospective
Completed
- Coronary Heart Disease
- Dual antiplatelet therapy with aspirin and either ticagrelor or clopidogrel
-
Hangzhou, Zhejiang, ChinaSecond affiliated Hospital Zhejiang University School of Medicin
Jul 31, 2023